
Overview
Polimed Research has introduced vascular therapies and medical equipment for heart and vascular diseases in Poland since 1994. It works with manufacturers, medical centers, and cardiologists; its projects focus on cardiac microcirculation, stroke, and cerebral aneurysms.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2026.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-01-30. Active
78 1050 1025 1000 0090 8679 8247
88 1050 1025 1000 0090 8108 7968
21 1050 1025 1000 0023 6708 0914
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 1,895PLN 1,895 |
Secured liabilities
| Type | Creditor | |
|---|---|---|
Registered pledge | ||
Registered pledge | ||
Registered pledge |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Mar 20, 2026 | Call to creditors |
Public aid
16 public aid cases recorded, with a total value of $8,168,128.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 3, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Banku Gospodarstwa Krajowego | |
| Jul 5, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezes Banku Gospodarstwa Krajowego | |
| Jul 5, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezes Banku Gospodarstwa Krajowego |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-06-01 | BIRSEN - urządzenie do usuwania skrzeplin w ostrej zatorowości płucnej | $3.3M$3,320,469 | Program Operacyjny Inteligentny Rozwój | |
| 2020-12-01 | LifeBuoy – urządzenie zmniejszające śmiertelność pacjentów z powodu ostrego rozwarstwienia aorty | $4.7M$4,698,830 | Program Operacyjny Inteligentny Rozwój |
Tenders
84 tenders recorded as contractor: 22 national ($1,299,214) and 62 EU ($97,953,071).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Sep 15, 2026 | Dostawy sukcesywne sprzętu jednorazowego użytku dla Pracowni Hemodynamiki na okres 24 miesięcy | –– | 10 Wojskowy Szpital Kliniczny z Polikliniką Samodzielny Publiczny Zakład Opieki Zdrowotnej | |
| Sep 3, 2026 | Dostawa wyrobów medycznych do inwazyjnych zabiegów kardiologicznych | –– | Górnośląskie Centrum Medyczne Im. Prof. Leszka Gieca Śląskiego Uniwersytetu Medycznego w Katowicach | |
| Sep 2, 2026 | Wyroby medyczne jednorazowego użytku - dla Pracowni Hemodynamiki Serca | –– | Uniwersytecki Szpital Kliniczny w Poznaniu |
Public sector contracts
Polimed Research is the contractor in 6 public sector contracts, worth PLN 991.84k in total. They were signed with 6 public buyers.
| Public buyer | Value | |
|---|---|---|
| Samodzielny Publiczny Zakład Opieki Zdrowotnej Uniwersytecki Szpital Kliniczny Nr 2 Uniwersytetu Medycznego w Łodzi | PLN 1,500 | |
| Wojewódzki Szpital Specjalistyczny w Legnicy | PLN 230,000 | |
| 10 Wojskowy Szpital Kliniczny z Polikliniką | PLN 597,500 | |
| Wojewódzki Szpital Zespolony w Płocku | PLN 44,400 | |
| Uniwersytecki Szpital Kliniczny w Poznaniu | PLN 1,800 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Manner of representation
Each member of the management board independently is authorised to make declarations concerning the company's property and non-property rights and obligations and to sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Wojciech Dobkowski | 35 | $4,727.17 | 97.2222% |
Others | 1 | $135.06 | 2.7778% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| PromedS.A. | $12,643,674.56 | promed.com.pl | ||
| Neomed Polskasp. z o.o. | $8,871,033.54 | neomedpolska.pl | ||
| MassmedicaS.A. | $8,216,274.00 | massmedica.com | ||
| Biochem PolskaS.A. | $7,311,179.43 | biochempolska.pl | ||
| Mindray Medical Polandsp. z o.o. | $6,479,161.67 | mindray.com | ||
| Polmilsp. z o.o. | $6,332,250.91 | polmil.pl | ||
| Medmess Kropaczewskisp. k. | $4,516,614.15 | medmess.pl | ||
| LM Linesp. z o.o. | $3,541,531.01 | lmline.pl | ||
| Reynolds Medicalsp. z o.o. | $3,313,657.78 | reymed.pl | ||
| Eumedsp. z o.o. | $2,086,044.24 | eumed.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-07-21 | Share capital change (240,000.00 PLN → 18,000.00 PLN) | |
| 2023-11-23 | Address change (Ul. Poleczki 40, 02-822, Warszawa → Ul. Poleczki 12, 02-822, Warszawa) | |
| 2022-11-10 | Address change (Poleczki 12, 02-822, Warszawa → Ul. Poleczki 40, 02-822, Warszawa) | |
| 2021-07-19 | Name change (Polimed → Polimed Research) | |
| 2021-04-12 | Share capital change (740,000.00 PLN → 240,000.00 PLN) |
FAQ
Last updated: 2026-08-19